Meidi Utami Puteri (Meidi U Puteri)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Epithelial Mesenchymal Transition

Breast Cancer Cells

Low Density Lipoprotein

Protein Protein

Top Venues

Life (Basel, Switzerland)

Journal of cardiovascular development and disease

This page only lists publications with an associated author ORCID identifier.

Publications

Muttia Amalia, Meidi Utami Puteri, Fadlina Chany Saputri, Rani Sauriasari, Bambang Widyantoro
Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients. Life (Basel, Switzerland) 13 (7) (2023)
Fadlina Chany Saputri, Nuriza Ulul Azmi, Meidi Utami Puteri, null Damayanti, Vivi Novita, Gracia Marisi, Elin Oktavira, Aninda Novika Sari, Khairunisa Ronaningtyas, Enny Herawati
High-Fat Diet Enhances Platelet Activation and Is Associated with Proprotein Convertase Subtilisin Kexin 9: An Animal Study. Nutrients 15 (20) (2023)
Muhammad Iqbal, Nur Hasanah, Aimee Detria Arianto, Widya Dwi Aryati, Meidi Utami Puteri, Fadlina Chany Saputri
Brazilin from Caesalpinia sappan L. as a Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor: Pharmacophore-Based Virtual Screening, In Silico Molecular Docking, and In Vitro Studies. Advances in pharmacological and pharmaceutical sciences 2023 (2023)
Meidi Utami Puteri, Nuriza Ulul Azmi, Mitsuyasu Kato, Fadlina Chany Saputri
PCSK9 Promotes Cardiovascular Diseases: Recent Evidence about Its Association with Platelet Activation-Induced Myocardial Infarction. Life (Basel, Switzerland) 12 (2) (2022)
Meidi Utami Puteri, Nuriza Ulul Azmi, Salbiah Ridwan, Muhammad Iqbal, Tresni Fatimah, Tri Diana Puspita Rini, Mitsuyasu Kato, Fadlina Chany Saputri
Recent Update on PCSK9 and Platelet Activation Experimental Research Methods: In Vitro and In Vivo Studies. Journal of cardiovascular development and disease 9 (8) (2022)
Md Anwarul Haque, Mohammed Abdelaziz, Meidi Utami Puteri, Thanh Thao Vo Nguyen, Kosei Kudo, Yukihide Watanabe, Mitsuyasu Kato
PMEPA1/TMEPAI Is a Unique Tumorigenic Activator of AKT Promoting Proteasomal Degradation of PHLPP1 in Triple-Negative Breast Cancer Cells. Cancers 13 (19) (2021)
Meidi Utami Puteri, Yukihide Watanabe, Bantari W K Wardhani, Riezki Amalia, Mohammed Abdelaziz, Mitsuyasu Kato
PMEPA1/TMEPAI isoforms function via its PY and Smad-interaction motifs for tumorigenic activities of breast cancer cells. Genes to cells : devoted to molecular & cellular mechanisms 25 (6) (2020)
Bantari W K Wardhani, Meidi Utami Puteri, Yukihide Watanabe, Melva Louisa, Rianto Setiabudy, Mitsuyasu Kato
TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel. Journal of experimental pharmacology 12 (2020)